EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Iron therapy mitigates chronic kidney disease progression by regulating intracellular iron status of kidney macrophages

Edwin Patino, Divya Bhatia, Steven Z Vance, Ada Antypiuk, Rie Uni, Chantalle Campbell, Carlo G Castillo, Shahd Jaouni, Francesca Vinchi, Mary E Choi, Oleh Akchurin

JCI Insight · 10.01.2023 · 8 (1)

DOI: 10.1172/jci.insight.159235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, online erschienen am 10.01.2023. Verfasst von Edwin Patino und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Iron Deficiencies. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic iron metabolism is disrupted in chronic kidney disease (CKD). However, little is known about local kidney iron homeostasis and its role in kidney fibrosis. Kidney-specific effects of iron therapy in CKD also remain elusive. Here, we elucidate the role of macrophage iron status in kidney fibrosis and demonstrate that it is a potential therapeutic target. In CKD, kidney macrophages exhibited depletion of labile iron pool (LIP) and induction of transferrin receptor 1, indicating intracellular iron deficiency. Low LIP in kidney macrophages was associated with their defective antioxidant response and proinflammatory polarization. Repletion of LIP in kidney macrophages through knockout of ferritin heavy chain ( Fth1 ) reduced oxidative stress and mitigated fibrosis. Similar to Fth1 knockout, iron dextran therapy, through replenishing macrophage LIP, reduced oxidative stress, decreased the production of proinflammatory cytokines, and alleviated kidney fibrosis. Interestingly, iron markedly decreased TGF-β expression and suppressed TGF-β–driven fibrotic response of macrophages. Iron dextran therapy and FtH suppression had an additive protective effect against fibrosis. Adoptive transfer of iron-loaded macrophages alleviated kidney fibrosis, validating the protective effect of iron-replete macrophages in CKD. Thus, targeting intracellular iron deficiency of kidney macrophages in CKD can serve as a therapeutic opportunity to mitigate disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicIron DeficienciesHumansIronDextransKidneyMacrophagesIron-Dextran ComplexFibrosisTransforming Growth Factor beta

Stichwörter der Autor:innen

Chronic kidney diseaseFibrosisMacrophagesNephrology

Substanzen

IronDextransIron-Dextran ComplexTransforming Growth Factor beta

Autor:innen und Institutionen

  • Division of Nephrology and Hypertension, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
  • Iron Research Laboratory, Lindsley Kimball Research Institute, New York Blood Center, New York, New York, USA.
  • Division of Pediatric Nephrology, Department of Pediatrics, Weill Cornell Medicine, New York, New York, USA.
  • College of Agriculture and Life Sciences, Cornell University, Ithaca, New York, USA.
  • Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS
  • NIDDK NIH HHS
  • NIH NIDDK
  • Weill Cornell Medical College
  • The Hartwell Foundation

Zitieren

APA

Patino, E., Bhatia, D., Vance, S. Z., Antypiuk, A., Uni, R., Campbell, C., Castillo, C. G., Jaouni, S., Vinchi, F., Choi, M. E., & Akchurin, O. (2023). Iron therapy mitigates chronic kidney disease progression by regulating intracellular iron status of kidney macrophages. JCI Insight, 8(1). https://doi.org/10.1172/jci.insight.159235

Vancouver

Patino E, Bhatia D, Vance SZ, Antypiuk A, Uni R, Campbell C, et al. Iron therapy mitigates chronic kidney disease progression by regulating intracellular iron status of kidney macrophages. JCI Insight. 2023;8(1). doi:10.1172/jci.insight.159235

BibTeX
@article{Patino2023,
  author = {Patino, Edwin and Bhatia, Divya and Vance, Steven Z and Antypiuk, Ada and Uni, Rie and Campbell, Chantalle and Castillo, Carlo G and Jaouni, Shahd and Vinchi, Francesca and Choi, Mary E and Akchurin, Oleh},
  title = {Iron therapy mitigates chronic kidney disease progression by regulating intracellular iron status of kidney macrophages},
  journal = {JCI Insight},
  year = {2023},
  volume = {8},
  number = {1},
  doi = {10.1172/jci.insight.159235}
}
Kostenlos starten →